查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球血栓管理設備市場——行業規模、份額、趨勢、機會、預測、按產品類型、按最終用戶、按地區、競爭分析 (2018-2028)
市場調查報告書
商品編碼
1244126

全球血栓管理設備市場——行業規模、份額、趨勢、機會、預測、按產品類型、按最終用戶、按地區、競爭分析 (2018-2028)

Clot Management Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product Type, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 113 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

在 2024-2028 年的預測期內，全球血栓管理設備市場預計將實現穩定的複合年增長率。

這可能是由於隨著世界人口老齡化，心血管疾病增加。 此外，血栓管理設備的技術進步改善了中風等問題的診斷和治療，患者和醫療保健人員對微創手術的偏好增加，將在預測期內推動對血栓管理設備市場的需求增加。 久坐不動的生活方式、不健康的飲食以及髖、膝和脊柱損傷發生率的增加是預測期內推動全球血栓管理設備市場的一些關鍵因素。 在過去幾年中，與血栓管理設備相關的研究和臨床試驗顯著增加。

對支架回收器的需求不斷增長

支架取栓器是用於治療血栓性疾病的第二代機械取栓設備。 由於飲酒、吸煙、壓力、不健康食品和世界各地人口老齡化的增加，心血管疾病的患病率上升正在推動預測期內血栓管理設備市場的增長。 推動市場增長的關鍵因素之一是越來越多的血栓切除術報銷可用性，增加了對產品開發和商業化的公共和私人投資，以及患者對微創手術的關注度正在增加。 通過建立製造設施、研發設施和分銷網絡，主要參與者繼續進行藥物開發，市場參與者在新興國家擴大業務，這將是預測期內血栓管理設備市場增長的重要因素。

增加醫療保險報銷的可用性

隨著微創手術領域的技術不斷突破，醫院和外科中心現在正在使用取栓設備結合診斷技術來執行圖像引導的取栓術。. 由於在治療急性缺血性中風中支架和血栓切除裝置的使用增加以及慢性血管疾病發病率上升，醫院和外科中心進行血栓切除術的頻率正在增加。 除此之外，主要的市場參與者正專注於他們的研發部門，以生產用於血栓切除術設備的先進技術。 主要參與者正在與學術研究機構合作以獲得對正在進行的臨床項目的支持，並且有公共和私人資金支持血栓切除術領域的研究項目以開發新的血栓切除術技術。正在增加，這有望推動整體的增長預測期內的血栓管理設備市場。

市場細分

參與企業

Medtronic Plc.、Concentric Medical, Inc.、Boston Scientific Corporation、Edward Lifesciences Corporation、AngioDynamics, Inc.、LeMaitre Vascular, Inc.、Teleflex Incorporated、Johnson & Johnson、Strub Medical GmbH & Co.KG、Cook Group Incorporated等，是在全球血栓管理設備市場上運營的主要參與者之一。

範圍

本報告將全球血栓管理器械市場分為以下幾類，行業趨勢詳述如下：

血栓管理設備市場，按產品類型：

  • 神經血管栓塞裝置
  • 取栓球囊導管
  • 經皮取栓裝置
  • 導管定向溶栓裝置
  • 其他

最終用戶的血栓管理設備市場：

  • 用於醫院和診所
  • 門診中心
  • 其他

按地區劃分的血栓管理設備市場：

  • 北美
    • 美國
    • 墨西哥
    • 加拿大
  • 歐洲
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳大利亞
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿聯酋
    • 埃及
    • 土耳其人

競爭格局

公司概況：對全球血栓管理設備市場主要參與者的深入分析。

可自定義：

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家公司）進行深入分析和概況分析。

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素、挑戰和趨勢概述

第 4 章 VOC（客戶之聲）

第 5 章血栓管理設備的全球市場前景

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品類型（神經血管栓塞裝置、栓塞球囊導管、經皮取栓裝置、導管直接溶栓裝置等）
    • 按最終用戶（醫院/診所、門診診所、其他）
    • 按公司分類（2022 年）
    • 按地區
  • 市場地圖
    • 按產品類型
    • 最終用戶
    • 按地區

第6章北美血栓管理器械市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品類型
    • 最終用戶
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 墨西哥
    • 加拿大

第 7 章：歐洲血栓管理設備的市場前景

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品類型
    • 最終用戶
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第 8 章亞太地區血栓形成和止血設備市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品類型
    • 最終用戶
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳大利亞

第 9 章：南美血栓管理設備的市場前景

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品類型
    • 最終用戶
    • 按國家
  • 南美洲：：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章中東和非洲血栓和止血設備市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品類型
    • 最終用戶
    • 按國家
  • MEA：國家分析
    • 南非血栓形成裝置
    • 沙特阿拉伯血栓止血裝置
    • 阿聯酋血栓形成裝置
    • 埃及血栓止血器
    • 土耳其血栓治療儀

第 11 章市場動態

  • 司機
  • 任務

第12章市場趨勢與發展

  • 近期趨勢
  • 併購
  • 產品發布

第13章競爭格局

  • 業務概覽
  • 企業概況
  • 產品服務
  • 財務信息（公開數據）
  • 最新趨勢
  • SWOT 分析
    • Medtronic Plc.
    • Concentric Medical, Inc.
    • Boston Scientific Corporation
    • Edward LifeSciences Corporation
    • AngioDynamics, Inc.
    • LeMaitre Vascular, Inc.
    • Teleflex Incorporated
    • Johnson & Johnson
    • Strub Medical GmbH & Co. KG
    • Cook Group Incorporated

第14章 戰略建議

簡介目錄
Product Code: 14585

Global clot management devices market is expected to register a steady CAGR during the forecast period, 2024-2028. This can be ascribed to the increasing number of cardiovascular diseases along with the rising aging population across the world. Additionally, the advancement of technologies in clot management devices to improve the diagnosis and treatment of problems like stroke and the growing preference for minimally invasive procedures by both patients and healthcare increased the demand for the clot management device market for the forecast period. Sedentary lifestyles and unhealthy dietary habits and increasing instances of hip, knee, and spinal injuries across the globe, are some of the major factors driving the global clot management device market during the forecast period. The research and clinical trial related to clot management devices has significantly increased over the years.

Rising Demand for Stent Retrievers

Stent retrievers are second-generation mechanical thrombectomy products utilized for the treatment of thrombotic disorders. The increasing prevalence of cardiovascular disease because of the increase in alcohol consumption, smoking, stress, and unhealthy foods and the growing aging population across the world, are propelling the clot management device market growth during the forecast period. One of the important factors that drive the market growth is the increasing availability of reimbursement of thrombectomy procedures, rising public and private investments for product development and commercialization, and increasing patient emphasis on minimally invasive procedures. Ongoing drug developments by leading companies and expansion of the presence in emerging countries by the market players through the establishment of manufacturing facilities, research and development facilities, and distribution networks are the important factors that significantly contribute to the growth of the clot management devices market during the forecast period.

Increasing Availability of Medical Reimbursements

With continued technical breakthroughs in the field of minimally invasive operations, thrombectomy systems are currently being used in hospitals and surgical centers in collaboration with diagnostic technologies for image-guided thrombectomy procedures. The frequency of thrombectomy procedures performed in hospitals and surgical centers is rising due to the increased use of stent and clot retrievers in treating acute ischemic stroke and the rising incidence of chronic vascular illnesses. Apart from this, the main market players are focusing on the research and development sector to create advanced technology in thrombectomy devices. Major players are collaborating with academic and research institutes to get support on their ongoing clinical projects and rising public-private funding to support research projects in the field of thrombectomy to develop novel thrombectomy technology, which is expected to drive the overall clot management device market growth during the forecast period.

Market Segmentation

Global Clot Management Devices market is segmented based on product type, end-user, and region. Based on product type, the market can be segmented into neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis devices, and others. Based on end users, the market can be segmented into hospitals & clinics, ambulatory care centers, and others. Regionally, Europe dominated the market among Asia Pacific, North America, Middle East & Africa, and South America. In terms of country, the United States is dominating the global clot management devices market. This can be ascribed to the increasing number of cost-effective devices in the healthcare sector. According to the World Health Organization (WHO), the number of people suffering from deep vein thrombosis (DVT) and pulmonary embolism (PE) is much larger than people suffering from AIDS and cancer. During the year 2015, around 9,00,000 people were diagnosed with DVT & PE in the United States.

Market Players

Medtronic Plc., Concentric Medical, Inc., Boston Scientific Corporation, Edward Lifesciences Corporation, AngioDynamics, Inc., LeMaitre Vascular, Inc., Teleflex Incorporated, Johnson & Johnson, Strub Medical GmbH & Co. KG, Cook Group Incorporated are some of the leading players operating in the Global Clot Management Devices Market.

Report Scope:

In this report, Global Clot Management Devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clot Management Devices Market, By Product Type:

  • Neurovascular Embolectomy Devices
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
  • Catheter-Directed Thrombolysis Devices
  • Others

Clot Management Devices Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Clot Management Devices Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Clot Management Devices Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clot Management Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter Directed Thrombolysis Devices, Others)
    • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.3. By Company (2022)
    • 5.2.4. By Region
  • 5.3. Market Map
    • 5.3.1. By Product Type
    • 5.3.2. By End User
    • 5.3.3. By Region

6. North America Clot Management Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Clot Management Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Mexico Clot Management Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Canada Clot Management Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End User

7. Europe Clot Management Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Clot Management Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End User
    • 7.3.2. Germany Clot Management Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Clot Management Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Clot Management Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Clot Management Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By End User

8. Asia-Pacific Clot Management Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Clot Management Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Clot Management Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End User
    • 8.3.3. South Korea Clot Management Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End User
    • 8.3.4. Japan Clot Management Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Clot Management Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By End User

9. South America Clot Management Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Clot Management Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Clot Management Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Clot Management Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End User

10. Middle East and Africa Clot Management Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Clot Management Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Clot Management Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Clot Management Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By End User
    • 10.3.4. Egypt Clot Management Devices Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product Type
        • 10.3.4.2.2. By End User
    • 10.3.5. Turkey Clot Management Devices Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Product Type
        • 10.3.5.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Company Snapshot
  • 13.3. Products & Services
  • 13.4. Financials (As reported)
  • 13.5. Recent Developments
  • 13.6. SWOT Analysis
    • 13.6.1. Medtronic Plc.
    • 13.6.2. Concentric Medical, Inc.
    • 13.6.3. Boston Scientific Corporation
    • 13.6.4. Edward LifeSciences Corporation
    • 13.6.5. AngioDynamics, Inc.
    • 13.6.6. LeMaitre Vascular, Inc.
    • 13.6.7. Teleflex Incorporated
    • 13.6.8. Johnson & Johnson
    • 13.6.9. Strub Medical GmbH & Co. KG
    • 13.6.10. Cook Group Incorporated

14. Strategic Recommendations